Anaplastic Large Cell Lymphoma Alk-positive
📧 Sign up to get email alerts when something new happens for Anaplastic Large Cell Lymphoma Alk-positive.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-07Clinical Trial Update: A Study of Oral Lorlatinib in Patients With Relapsed ALK Positive Lymphoma [Phase 2]
Phase 2 study evaluating oral lorlatinib in patients with relapsed ALK-positive anaplastic large cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2023-04-19Clinical Trial Update: Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma [Phase 2]
Phase 2 trial evaluating brentuximab vedotin in combination chemotherapy for CD30-positive peripheral T-cell lymphomas reports results poste…
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Pilot Study of Crizotinib in Relapsed ALK+ Lymphomas [Phase 2]
Phase 2 pilot study update of crizotinib in relapsed ALK-positive anaplastic large cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating combination chemotherapy with lenalidomide in newly diagnosed peripheral T-cell lymphoma (multiple subtypes) ha…
-
CLINICAL_TRIALS trial_result · 2014-06-27Clinical Trial Update: Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma [Phase 2]
A completed Phase 2 study evaluating the combination of bortezomib and panobinostat in relapsed or refractory peripheral T-cell lymphomas an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.